Clinical Trial Update: Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months

View source ↗

Summary

A completed clinical trial evaluating the effects of Copaxone (glatiramer acetate) on retinal health in multiple sclerosis patients using optical coherence tomo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: University at Buffalo | Conditions: Multiple Sclerosis | Status: COMPLETED